4-5: LDL of 190+ and Diabetes Benefit Groups

0.0(0)
studied byStudied by 1 person
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/10

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

11 Terms

1
New cards

LDL of 190+: Provide the values for someone within this scenario-

LDL of 190+ on HI Statin

  • Goal: ? decrease in LDL

  • LDL Threshold: ?

  • Non-HDL: ?

  • 50% +

  • 100 or less

  • 130 or less

2
New cards

LDL of 190+: Provide the additional non-statin therapies for someone within this scenario-

LDL of 190+ on HI Statin

  • 1st line therapy ?

  • 2nd line therapy ?

  • 3rd line therapy ?

  • ezetimibe and or pcsk9i → whichever not added above

  • bempedoic acid or inclisiran

  • evinacumab, lomatipide, and/or LDL apheresis if history of familial hypercholesterolemia

3
New cards

Diabetes: If a patient is in the age range of 40-75 years old, what is the statin intensity you can use for treatment INITIALLY?

moderate intensity

4
New cards

Diabetes: Provide the values for someone within this scenario-

Diabetes → lifestyle → 40-75 years old → moderate/ high intensity statin

  • Goal: ? decrease in LDL

  • LDL Threshold: ?

  • Non-HDL: ?

  • 30% +

  • 100 or less

  • 130 or less

5
New cards

Diabetes: After initiating initial treatment, what do you do if the patient is not at goal?

calculate their ASCVD score

6
New cards

Diabetes: What are the 3 treatment pathways based on ASCVD risk score?

  1. 7.5% or less

  2. 7.5% + or multiple DM-specific risk enhancing factors (high risk)

  3. 20% or more

7
New cards

Diabetes: What are the 7 DM-specific risk enhancing factors?

  1. 10+ year duration of type 2

  2. 20+ year duration of type 1

  3. albuminuria of 30+

  4. eGFR less than 60

  5. retinopathy (eye damage)

  6. neuropathy (nerve damage)

  7. ABI less than 0.9

8
New cards

Diabetes: What is the treatment pathway for someone with ASCVD risk score of 7.5% or less?

remain on moderate intensity statin AND continue to monitor

9
New cards

Diabetes: What is the treatment pathway for someone with an ASCVD risk score of 7.5% or more OR with multiple DM-specific REFs?

  • initiate ? intensity statin

THEN

  • Goal: ? decrease in LDL

  • LDL Threshold: ?

  • Non-HDL: ?

  • high intensity statin

    THEN

  • 50% or more

  • 70 or less

  • 100 or less

10
New cards

Diabetes: What is the treatment pathway for someone with an ASCVD risk score of 20% or more?

  • initiate ? intensity statin

    THEN

  • Goal: ? decrease in LDL

  • LDL Threshold: ?

  • Non-HDL: ?

    THEN

  • add ?

  • high intensity statin

    THEN

  • 50% or more

  • 70 or less

  • 100 or less

    THEN

  • add ezetimibe

11
New cards

Diabetes: When is the only time that additional non-statin therapy is used and which treatment is added?

If a patient has diabetes w/ a ASCVD risk score of 20% or higher and has not reached goal after initiating a high intensity statin.

  • Only ezetimibe is added